Adawi Kamal sold FATE
November 3, 2026 · Form 4 insider transaction
Adawi Kamal sold 6,582 shares of Fate Therapeutics, Inc. at $2.05 per share, a transaction worth $13.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 18,750 shares of Common Stock underlying RSUs granted to the Reporting Person on October 20, 2025. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through "sell-to-cover" transactions and were not made at the discretion of the Reporting Person.; Represents the weighted average sale price of the shares sold ranging from $2.020 to $2.084 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.